Australia and New Zealand's Only Conference on Biologics: From Discovery to Delivery
Excellence in Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics for Australia & New Zealand's Future Biologics Industry
With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers, and regulation, the ANZ region has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such, partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia & New Zealand will also play a massive role in uplifting the sector in the region.
The 3rd ANZ Biologics Festival 2025 is the region's premier conference that aims to gather the innovators, pioneers, and leaders in the biologics fraternity, including Biologics, Biosimilars, Vaccines, Cell and Gene Therapy (CGT), and RNA Therapeutics, to showcase the latest from ideation to commercialization phase and beyond. It provides the right environment to meet the entire biopharma fraternity under one roof.
Join us to bring investment to Australia & New Zealand's bio sector and explore a wealth of opportunities in biologics innovation, expanding the region's manufacturing footprint, and advancing cell and gene therapy and RNA therapeutics. The 2025 festival will feature dedicated tracks on Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics, offering a comprehensive view of the latest advancements and challenges in these critical areas.
FINAL CALL
*END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, APAC Academic & Research Institutes in APAC (including ANZ)
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
FINAL CALL
*END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes outisde of APAC
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
FINAL CALL
*SOLUTION PROVIDER PRICING IS APPLICABLE TO:
Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.
Job Profiles: Business Development, Marketing & Sales
FINAL CALL
*END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, APAC Academic & Research Institutes in APAC (including ANZ)
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
FINAL CALL
*END-USER PRICING IS APPLICABLE TO:
Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes outisde of APAC
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
FINAL CALL
*SOLUTION PROVIDER PRICING IS APPLICABLE TO:
Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.
Job Profiles: Business Development, Marketing & Sales
In an attempt to capture the essence of the expanding ANZ Biotech industry, the 3rd ANZ Biologics Festival 2025 brings together thought leaders to discuss current trends, opportunities, and to brainstorm ways to navigate through myriad challenges.
We welcome you to present your research on the following relevant themes including:
We're open to other topic proposals as well! Contact [email protected] at the button below to secure a spot for your poster presentation.
2:00 PM - 6:00 PM
3rd February 2025
We are delighted to invite you to Sartorius' Cell & Gene Therapy Workshop in Melbourne on 3rd February 2025. Our event is designed for professionals working on cell and gene therapies, offering tailored sessions on end-to-end solutions that deliver reproducible performance and scalability with a simplified path to regulatory approvals.
Don’t miss this opportunity to connect, learn, and collaborate with industry experts and peers in hands-on sessions.
Highlights:
9:00 AM – 12:00 PM
6th February 2025
IDT Australia is a leading cGMP pharmaceutical manufacturing company with over 50 years of operational excellence. The company has been instrumental in bringing 30 novel chemical entities to the market and is known as a “go-to” expert partner for the production and manufacturing of pharmaceuticals.
IDT Australia offers unique capabilities in cutting-edge technologies, including mRNA-based therapeutics and Antibody Drug Conjugates (ADCs), making them a leader in the development of advanced therapies. The company's expertise extends to psychedelic treatments for mental health, and their robust capabilities include Modified Release and Targeted Medicine technologies.
Key Highlights of the Facility:
Participants will also have the chance to explore IDT Australia’s world-class facilities, including high containment areas for ADC production, pilot scale facilities, and sterile fill and finish suites. These capabilities make IDT an ideal partner for the development and manufacturing of complex biologics, mRNA vaccines, and advanced therapies.
This site tour will provide a comprehensive view of IDT Australia’s innovative technologies, expertise, and facilities, offering insights into the future of biologics and advanced therapeutic manufacturing in Australia.
Click here for site tour details.
Very educating and inspiring. I thought that careful thought was put into the topics and time allotted for the presentation
The most representative conference I have been to yet in Australia of the challenges and capabilities of Australian biologics, particularly cell and gene therapy. When I saw 'biologics festival', I thought it would focus mainly on therapeutic recombinant proteins and antibodies, but the spread of gene and cell therapy included was worth attending for!
Greatly appreciated the efforts by the organisers to arrange scheduled meetings with KOLs present at the conference. This was an initiative that I hadn't previously seen take place elsewhere and it allowed for fruitful discussion and engagement between attendees and booth exhibitors.
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.